The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Tyler Menichiello, chief editor at Bioprocess Online, host of the Better Biopharma podcast, and my Life Science Connect (LSC) colleague, convenes the broader LSC editorial team once again for a midyear discussion on what's happening now in the life sciences industry, and what's to come in the second half of the year. Topics include AI manufacturing regulations and navigating supply chain...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Business Of Biotech
Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D.
Late-Stage Development And Commercial Planning With CervoMed's Matt Winton, Ph.D.
BoB@BIO: Biotech In The Balance With Ovid Therapeutics' Dr. Jeremy Levin
BoB@BIO: Biotech Investing And Deals With Sofinnova's Maha Radhakrishnan, M.D.
Get summaries like this every morning.
Free AI-powered recaps of Business Of Biotech and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.